Pathophysiology of Diabetes
Peripheral Artery Disease I: Introduction
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 2, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Shumin Wang1, Huimin Liu1, Wanrong Huang2
1Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
The 2023 ACR-EULAR criteria refine antiphospholipid syndrome (APS) understanding, highlighting obstetric APS (OAPS) as a distinct subtype. OAPS pathogenesis involves multifactorial causes beyond thrombosis, including placental and immune dysfunction.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: